高级检索
当前位置: 首页 > 详情页

Where Hepatitis B and Hepatitis E Meet: Epidemiological and Clinical Aspects

文献详情

资源类型:
WOS体系:

收录情况: ◇ SCIE

单位: [1]Huazhong Univ Sci & Technol,Tongji Hosp,Tongji Med Coll,Dept & Inst Infect Dis,Wuhan,Hubei,Peoples R China [2]Catholic Univ Hlth & Allied Sci, Weill Sch Med, Dept Internal Med, Mwanza, Tanzania
出处:
ISSN:

关键词: Hepatitis B Hepatitis E Coinfection Epidemiology Clinical Review

摘要:
Hepatitis E virus (HEV) superinfection has a significant impact on a natural course of chronic hepatitis B (CHB) patients with underlying chronic liver disease (CLD). These patients usually present with increased symptoms, rapid decompensation to liver failure, and increased mortality. An increasing rate of HEV infections worldwide with uncertainties in its prevention and treatment raises a great concern to this group of patients. Therefore, in this article, we reviewed recent studies describing the epidemiological patterns of HEV and Hepatitis B virus (HBV), both mono and dual infections. We also reviewed the literature on clinical interaction among HBV/HEV-superinfected patients with CLD and the potential preventive strategies.

语种:
WOS:
中科院(CAS)分区:
出版当年[2018]版:
大类 | 4 区 医学
小类 | 4 区 胃肠肝病学
最新[2025]版:
大类 | 4 区 医学
小类 | 4 区 胃肠肝病学
JCR分区:
出版当年[2017]版:
Q4 GASTROENTEROLOGY & HEPATOLOGY
最新[2023]版:
Q4 GASTROENTEROLOGY & HEPATOLOGY

影响因子: 最新[2023版] 最新五年平均 出版当年[2017版] 出版当年五年平均 出版前一年[2016版] 出版后一年[2018版]

第一作者:
第一作者单位: [1]Huazhong Univ Sci & Technol,Tongji Hosp,Tongji Med Coll,Dept & Inst Infect Dis,Wuhan,Hubei,Peoples R China [2]Catholic Univ Hlth & Allied Sci, Weill Sch Med, Dept Internal Med, Mwanza, Tanzania
通讯作者:
推荐引用方式(GB/T 7714):
APA:
MLA:

相关文献

[1]Combining Hepatitis B Virus RNA and Hepatitis B Core-Related Antigen: Guidance for Safely Stopping Nucleos(t)ide Analogues in Hepatitis B e Antigen-Positive Patients With Chronic Hepatitis B [2]Superinfective Hepatitis E Virus Infection Aggravates Hepatocytes Injury in Chronic Hepatitis B [3]Randomized, three-arm study to optimize lamivudine efficacy in hepatitis B e antigen-positive chronic hepatitis B patients [4]Tenofovir Alafenamide Versus Tenofovir Disoproxil Fumarate for Treatment of Hepatitis B e Antigen-Negative Hepatitis B (China) [5]HBsAg and HBeAg in the prediction of a clinical response to peginterferon alpha-2b therapy in Chinese HBeAg-positive patients [6]Vebicorvir, entecavir, and pegylated interferon in patients with hepatitis B e antigen positive chronic hepatitis B virus infection: findings from a phase 2, randomized open-label study in China [7]An Analysis of Epidemiological Characteristics and the Clinical Features of 394 Cases of Sporadic Acute Hepatitis E in Southwest China from 2008 to 2010 [8]慢性乙型肝炎临床免疫学研究进展 [9]BASELINE PERIPHERAL NK AND ITS EARLY DYNAMIC CHANGES PREDICTS 24 WEEKS TREATMENT EFFICACY IN HEPATITIS B E ANTIGEN POSITIVE CHRONIC HEPATITIS PATIENTS - A SINGLE CENTER EXPERIENCE FROM 54 PATIENTS TREATED WITH TELBIVUDINE (LDT) [10]BASELINE CD4+CD25+CD127LOW/- TREGS AND ITS EARLY DYNAMIC CHANGES PREDICTS 24 WEEKS TREATMENT EFFICACY IN HEPATITIS B E ANTIGEN POSITIVE CHRONIC HEPATITIS PATIENTS - A SINGLE CENTER EXPERIENCE FROM 54 PATIENTS TREATED WITH TELBIVUDINE (LDT)

资源点击量:589 今日访问量:0 总访问量:441 更新日期:2025-06-01 建议使用谷歌、火狐浏览器 常见问题

版权所有:重庆聚合科技有限公司 渝ICP备12007440号-3 地址:重庆市两江新区泰山大道西段8号坤恩国际商务中心16层(401121)